0000950170-24-107532.txt : 20240917
0000950170-24-107532.hdr.sgml : 20240917
20240917201102
ACCESSION NUMBER: 0000950170-24-107532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240916
FILED AS OF DATE: 20240917
DATE AS OF CHANGE: 20240917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CORNELIUS JAMES M
CENTRAL INDEX KEY: 0001198959
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42272
FILM NUMBER: 241305897
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MBX Biosciences, Inc.
CENTRAL INDEX KEY: 0001776111
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: 3179893100
MAIL ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
4
1
ownership.xml
4
X0508
4
2024-09-16
false
0001776111
MBX Biosciences, Inc.
MBX
0001198959
CORNELIUS JAMES M
C/O MBX BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 300
CARMEL
IN
46032
true
false
false
false
false
Common Stock
2024-09-16
4
C
false
102082
A
102082
D
Series A Convertible Preferred Stock
2024-09-16
4
C
false
994069
D
Common Stock
82686
0
D
Series B Convertible Preferred Stock
2024-09-16
4
C
false
233192
D
Common Stock
19396
0
D
Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (together, the "Preferred Stock") was convertible into Common Stock on a one-for-12.0221 basis at any time at the option of the holder, and automatically converted into the number of shares shown in Column 7 immediately prior to the closing of the Issuer's initial public offering on September 16, 2024. The Preferred Stock had no expiration date.
/s/ Richard Bartram, attorney-in-fact
2024-09-17